InSitu Biologics, Inc

CIK 1723443 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for InSitu Biologics, Inc.

Recent SEC filings

FiledFormAccession number
Aug 10, 2026D0001723443-26-000005
Dec 18, 2025D0001723443-25-000003
Dec 29, 2023D0001790300-23-000004
Feb 25, 2021D0001790300-21-000002
Dec 30, 20201-Z0001437749-20-026146
Sep 17, 20201-K0001477932-20-005441
May 1, 20201-U0001477932-20-002332
Oct 21, 2019253G20001477932-19-005974
Oct 1, 20191-SA0001477932-19-005627
Sep 3, 20191-U0001477932-19-005252
Aug 6, 2019253G20001477932-19-004538
Aug 5, 2019253G20001477932-19-004506
Jul 24, 20191-K0001477932-19-004276
Mar 27, 2019QUALIF9999999994-19-000035
Mar 27, 20191-A POS0001477932-19-001196
Mar 25, 20191-A POS0001477932-19-001151
Jan 4, 20191-A POS0001477932-19-000024
Oct 12, 2018253G20001477932-18-004844
Oct 10, 20181-SA0001477932-18-004786
Aug 7, 2018253G20001477932-18-003843
Aug 1, 2018253G20001477932-18-003754
Jul 17, 2018CT ORDER9999999997-18-006956
Jul 17, 2018QUALIF9999999994-18-000151
Jul 16, 20181-A/A0001477932-18-003545
Jul 11, 20181-A/A0001477932-18-003448